Annual EBITDA
-$54.06 M
+$20.33 M+27.33%
December 31, 2024
Summary
- As of March 14, 2025, IKNA annual EBITDA is -$54.06 million, with the most recent change of +$20.33 million (+27.33%) on December 31, 2024.
- During the last 3 years, IKNA annual EBITDA has fallen by -$20.47 million (-60.93%).
- IKNA annual EBITDA is now -196.26% below its all-time high of -$18.25 million, reached on December 31, 2019.
Performance
IKNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$12.09 M
-$581.00 K-5.05%
December 31, 2024
Summary
- As of March 14, 2025, IKNA quarterly EBITDA is -$12.09 million, with the most recent change of -$581.00 thousand (-5.05%) on December 31, 2024.
- Over the past year, IKNA quarterly EBITDA has stayed the same.
- IKNA quarterly EBITDA is now -509.00% below its all-time high of $2.96 million, reached on December 31, 2021.
Performance
IKNA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$54.06 M
+$9.52 M+14.97%
December 31, 2024
Summary
- As of March 14, 2025, IKNA TTM EBITDA is -$54.06 million, with the most recent change of +$9.52 million (+14.97%) on December 31, 2024.
- Over the past year, IKNA TTM EBITDA has stayed the same.
- IKNA TTM EBITDA is now -661.25% below its all-time high of -$7.10 million, reached on March 31, 2020.
Performance
IKNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IKNA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.3% | 0.0% | 0.0% |
| 3 y3 years | -60.9% | +33.8% | +18.2% |
| 5 y5 years | -196.3% | +33.8% | +18.2% |
IKNA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -60.9% | +27.3% | -509.0% | +44.0% | -60.9% | +27.5% |
| 5 y | 5-year | -196.3% | +27.3% | -509.0% | +53.5% | -661.3% | +27.5% |
| alltime | all time | -196.3% | +27.3% | -509.0% | +53.5% | -661.3% | +27.5% |
Ikena Oncology EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$54.06 M(-27.3%) | -$12.09 M(+5.0%) | -$54.06 M(-15.0%) |
| Sep 2024 | - | -$11.51 M(-23.5%) | -$63.58 M(-10.9%) |
| Jun 2024 | - | -$15.05 M(-2.4%) | -$71.34 M(-4.3%) |
| Mar 2024 | - | -$15.43 M(-28.6%) | -$74.54 M(+0.2%) |
| Dec 2023 | -$74.40 M(+6.0%) | -$21.60 M(+12.2%) | -$74.40 M(+9.9%) |
| Sep 2023 | - | -$19.26 M(+5.6%) | -$67.70 M(+2.4%) |
| Jun 2023 | - | -$18.25 M(+19.4%) | -$66.10 M(-3.7%) |
| Mar 2023 | - | -$15.28 M(+2.5%) | -$68.65 M(-2.1%) |
| Dec 2022 | -$70.15 M | -$14.90 M(-15.6%) | -$70.15 M(+34.2%) |
| Sep 2022 | - | -$17.66 M(-15.1%) | -$52.29 M(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$20.80 M(+24.0%) | -$49.01 M(+20.3%) |
| Mar 2022 | - | -$16.78 M(-667.9%) | -$40.74 M(+21.3%) |
| Dec 2021 | -$33.59 M(-24.0%) | $2.96 M(-120.6%) | -$33.59 M(-46.3%) |
| Sep 2021 | - | -$14.38 M(+14.6%) | -$62.53 M(+15.0%) |
| Jun 2021 | - | -$12.54 M(+30.2%) | -$54.38 M(+17.3%) |
| Mar 2021 | - | -$9.63 M(-62.9%) | -$46.36 M(+5.8%) |
| Dec 2020 | -$44.22 M(+142.3%) | -$25.98 M(+316.8%) | -$43.83 M(+145.5%) |
| Sep 2020 | - | -$6.23 M(+38.0%) | -$17.85 M(+53.6%) |
| Jun 2020 | - | -$4.52 M(-36.4%) | -$11.62 M(+63.6%) |
| Mar 2020 | - | -$7.10 M | -$7.10 M |
| Dec 2019 | -$18.25 M | - | - |
FAQ
- What is Ikena Oncology annual EBITDA?
- What is the all time high annual EBITDA for Ikena Oncology?
- What is Ikena Oncology annual EBITDA year-on-year change?
- What is Ikena Oncology quarterly EBITDA?
- What is the all time high quarterly EBITDA for Ikena Oncology?
- What is Ikena Oncology quarterly EBITDA year-on-year change?
- What is Ikena Oncology TTM EBITDA?
- What is the all time high TTM EBITDA for Ikena Oncology?
- What is Ikena Oncology TTM EBITDA year-on-year change?
What is Ikena Oncology annual EBITDA?
The current annual EBITDA of IKNA is -$54.06 M
What is the all time high annual EBITDA for Ikena Oncology?
Ikena Oncology all-time high annual EBITDA is -$18.25 M
What is Ikena Oncology annual EBITDA year-on-year change?
Over the past year, IKNA annual EBITDA has changed by +$20.33 M (+27.33%)
What is Ikena Oncology quarterly EBITDA?
The current quarterly EBITDA of IKNA is -$12.09 M
What is the all time high quarterly EBITDA for Ikena Oncology?
Ikena Oncology all-time high quarterly EBITDA is $2.96 M
What is Ikena Oncology quarterly EBITDA year-on-year change?
Over the past year, IKNA quarterly EBITDA has changed by $0.00 (0.00%)
What is Ikena Oncology TTM EBITDA?
The current TTM EBITDA of IKNA is -$54.06 M
What is the all time high TTM EBITDA for Ikena Oncology?
Ikena Oncology all-time high TTM EBITDA is -$7.10 M
What is Ikena Oncology TTM EBITDA year-on-year change?
Over the past year, IKNA TTM EBITDA has changed by $0.00 (0.00%)